PHK
VIR icon

Point72 Hong Kong’s Vir Biotechnology VIR Stock Holding History

Point72 Hong Kong’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,572
Closed -$174K – 659
2024
Q2 		$174K Buy
19,572
+12,598
+181% +$121K 0.01% 303
2024
Q1 		$70.7K Sell
6,974
-6,579
-49% -$67K ﹤0.01% 440
2023
Q4 		$136K Buy
+13,553
New +$124K 0.01% 460
2022
Q4 		– Sell
-19,642
Closed -$379K – 1632
2022
Q3 		$379K Buy
+19,642
New +$499K 0.01% 840
2022
Q2 		– Sell
-6,835
Closed -$176K – 2443
2022
Q1 		$176K Buy
+6,835
New +$203K 0.01% 1008
2021
Q3 		– Sell
-7,565
Closed -$358K – 2465
2021
Q2 		$358K Buy
+7,565
New +$344K 0.01% 1001

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Point72 Hong Kong's VIR Position: Q3 2024 in Review

Point72 Hong Kong sold out of Vir Biotechnology (VIR) in Q3 2024, closing a stake of 19,572 shares — an estimated $174K sold.

Point72 Hong Kong first reported a position in VIR in Q2 2021 and held it in 6 quarters. The position peaked at $379K in Q3 2022. 197 funds tracked by Wall St. Rank hold VIR as of Q3 2024.

  • Point72 Hong Kong reported no remaining Vir Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 19,572 Vir Biotechnology shares in Q3 2024, an estimated $174K.
  • Point72 Hong Kong first reported a position in Vir Biotechnology in Q2 2021 and held it in 6 quarters.
  • Point72 Hong Kong's Vir Biotechnology position peaked at $379K in Q3 2022.
  • 197 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2024.

Based on Point72 Hong Kong's 13F filing for Q3 2024, filed 14 Nov 2024.